✦ LIBER ✦

Glycoprotein IIb/IIIa inhibitor associated severe thrombocytopenia in patients with coronary artery disease: Clinical course and outcomes

✍ Scribed by Viswanathan, Girish; Kidambi, Ananth; Nelson, Adam; Mayurathan, Gnanamoorthy; Hardy, John; Kesteven, Patrick; Zaman, Azfar

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

The use of glycoprotein IIb/IIIa inhibit

✍ Marc S Sabatine; Ik-Kyung Jang 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 386 KB

Gender differences in clinical outcome a

✍ Ioannis Iakovou; George Dangas; Roxana Mehran; Alexandra J. Lansky; Yoshio Kobay 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 72 KB

Efficacy and safety of argatroban with o

✍ Ignacio Cruz-Gonzalez; Maria Sanchez-Ledesma; Suzanne J. Baron; Josephine L. Hea 📂 Article 📅 2007 🏛 Springer US 🌐 English ⚖ 138 KB

The Clinical Profile and Outcomes Associ

✍ M. Sean McMurtry; Adriane M. Lewin; Merril L. Knudtson; William A. Ghali; P. Dia 📂 Article 📅 2011 🏛 Pulsus Group Inc 🌐 English ⚖ 706 KB

Glycoprotein IIb/IIIa platelet receptor

✍ C. Richard Conti 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 274 KB

1139-53 The long-term clinical results o

✍ Weon Kim; Myung Ho Jeong; Young Keun Ahn; Ju Han Kim; Young Joon Hong; Jeong Gwa 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 89 KB